| 标题 |
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Infectious Diseases 作者:David L. Paterson; Helmi Sulaiman; Po‐Yu Liu; Mark D. Chatfield; Mesut Yılmaz; et al 出版日期:2025-10-06 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)